Joel Greenblatt fit · Magic Formula — ROIC alto + EV/EBIT barato
Is Gyre Therapeutics, Inc. Common Stock (GYRE) a Joel Greenblatt Stock?
Partial match — either cheap or high-quality, but not both.
47/100
DSinais mistos
1/5 critérios atendidos
Os critérios de Joel Greenblatt, aplicados a GYRE
EBIT/EV yield ≥ 10%
chave1.7%
ROIC ≥ 25%
chave11.7%
EV/EBIT ≤ 12
57.2x
Gross margin ≥ 30%
95.5%
Como GYRE pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$731.67M
P/L (TTM)
55.7x
ROIC (TTM)
11.69%
Margem bruta
95.48%
Perguntas frequentes
What is GYRE's Joel Greenblatt fit score?
GYRE scores 47/100 on our Joel Greenblatt fit engine — grade D. Partial match — either cheap or high-quality, but not both.
Does Joel Greenblatt actually own GYRE?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends GYRE.
How often is this score updated?
GYRE's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Joel Greenblatt possua ou recomende GYRE pessoalmente.